Watch for the First Oral GLP-1 Agonist, Rybelsus, During Transitions of Care

Semaglutide (Rybelsus, reh-BEL-sus) will be the first ORAL GLP-1 agonist for type 2 diabetes....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login